​

Biodesix (BDSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BDSX Stock Forecast

Biodesix (BDSX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $20.00 and a low of $20.00. This represents a 26.98% increase from the last price of $15.75.

- $4 $8 $12 $16 $20 High: $20 Avg: $20 Low: $20 Last Closed Price: $15.75

BDSX Stock Rating

Biodesix stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

BDSX Price Target Upside V Benchmarks

TypeNameUpside
StockBiodesix26.98%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks24.41%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$20.00
Last Closing Price$15.75$15.75$15.75
Upside/Downside--26.98%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-5---5
Feb, 26-41--5
Jan, 26-41--5
Dec, 25-41--5
Nov, 25-41--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 19, 2025Canaccord Genuity$20.00$6.69198.95%26.98%
Sep 16, 2024Sung Ji NamScotiabank$3.00$1.8264.84%-80.95%
Jul 26, 2024Bill BonelloCraig-Hallum$3.00$1.6878.57%-80.95%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 27, 2026William BlairMarket PerformOutperformupgrade
May 14, 2025Lake StreetBuyBuyhold
May 14, 2025William BlairMarket Performdowngrade
Sep 16, 2024ScotiabankOutperforminitialise
Jul 26, 2024Craig-HallumBuyinitialise
May 13, 2024Cowen & Co.Buyinitialise

Financial Forecast

EPS Forecast

$-35 $-28 $-21 $-14 $-7 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-31.60$-31.00$-12.80$-6.60$-4.67---
Avg Forecast$-1.58$-1.44$-0.66$-0.35$-0.22$-0.15$-0.08$-0.01
High Forecast$-1.54$-1.40$-0.64$-0.34$-0.21$-0.12$-0.07$-0.01
Low Forecast$-1.62$-1.50$-0.68$-0.37$-0.23$-0.18$-0.08$-0.01
Surprise %1900.00%2052.78%1839.39%1785.71%2022.73%---

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$54.51M$38.21M$49.09M$71.32M$88.50M---
Avg Forecast$54.68M$39.31M$50.14M$70.78M$93.11M$115.37M$130.00M$155.70M
High Forecast$55.93M$40.45M$50.31M$73.33M$94.49M$116.16M$132.35M$161.32M
Low Forecast$53.79M$38.45M$49.97M$68.96M$91.73M$114.58M$127.65M$151.69M
Surprise %-0.33%-2.79%-2.09%0.77%-4.95%---

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-43.16M$-65.45M$-52.15M$-42.93M$-35.27M---
Avg Forecast$-129.50M$-118.64M$-53.84M$-28.84M$-17.91M$-12.59M$-6.20M$-821.13K
High Forecast$-126.75M$-115.27M$-52.19M$-27.69M$-17.20M$-10.07M$-5.95M$-793.63K
Low Forecast$-133.34M$-123.12M$-55.50M$-29.99M$-18.63M$-15.11M$-6.45M$-859.64K
Surprise %-66.67%-44.84%-3.15%48.85%96.87%---

BDSX Forecast FAQ

Is Biodesix stock a buy?

Biodesix stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Biodesix is a favorable investment for most analysts.

What is Biodesix's price target?

Biodesix's price target, set by 7 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $20 at the low end to $20 at the high end, suggesting a potential 26.98% change from the previous closing price of $15.75.

How does Biodesix stock forecast compare to its benchmarks?

Biodesix's stock forecast shows a 26.98% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (24.41%).

What is the breakdown of analyst ratings for Biodesix over the past three months?

  • March 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Biodesix’s EPS forecast?

Biodesix's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.15, marking a -96.79% decrease from the reported $-4.67 in 2025. Estimates for the following years are $-0.08 in 2027, and $-0.01 in 2028.

What is Biodesix’s revenue forecast?

Biodesix's average annual revenue forecast for its fiscal year ending in December 2026 is $115.37M, reflecting a 30.36% increase from the reported $88.5M in 2025. The forecast for 2027 is $130M, and $155.7M for 2028.

What is Biodesix’s net income forecast?

Biodesix's net income forecast for the fiscal year ending in December 2026 stands at $-12.59M, representing a -64.30% decrease from the reported $-35.265M in 2025. Projections indicate $-6.2M in 2027, and $-821K in 2028.